BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:U.S. DOD CDMRP - Multiple Sclerosis Research Program
DTSTART;VALUE=DATE:20220802
DTSTAMP:20260407T011326Z
UID:9f562f6f20c51ea8cddb07a15079e0e997805949df68429036e5c1c9
CATEGORIES:Call for proposal
DESCRIPTION:Through the Congressionally Directed Medical Research Program 
 (CDMRP)\, the Department of Defense is announcing the Multiple Sclerosis R
 esearch Program (MSRP) Awards. Four award programs are available:\n\n	The 
 FY22 Early Investigator Research Award supports research opportunities for
  individuals in the early stages of their careers\, under the guidance of 
 one or more designated Mentors such as Post-Doctoral Fellows\n	\n	The FY22
  Investigator-Initiated Research Award supports highly rigorous\, high-imp
 act research projects that have the potential to make an important contrib
 ution to Multiple Sclerosis research and/or patient care\n	 \n	The FY22 E
 xploration-Hypothesis Development Award supports the initial exploration o
 f innovative\, high-risk\, high-gain\, and potentially groundbreaking conc
 epts\n	 \n	The FY22 Clinical Trial Award supports the rapid implementatio
 n of clinical trials with the potential to have a significant impact on th
 e treatment or management of multiple sclerosis.\n\n\nDEADLINE:\n\n\n	FY22
  Early Investigator Research Award - Pre-Application (1 page): August 2\, 
 2022\, submission on October 3\, 2022\n	 \n	FY22 Investigator-Initiated R
 esearch Award - Pre-Application: June 23\, 2022\, submission on October 3\
 , 2022\n	 \n	FY22 Exploration-Hypothesis Development Award - Pre-Applicat
 ion: June 23\, 2022\, submission on October 3\, 2022\n	 \n	FY22 Clinical 
 Trial Award - Pre-Application: June 23\, 2022\, submission on October 3\, 
 2022\n\n\nFUNDING:\n\n\n	FY22 Early Investigator Research Award - Anticipa
 ted total costs will not exceed $320\,000 for 2 years period of performanc
 e\n	 \n	FY22 Investigator-Initiated Research Award - Anticipated total co
 sts will not exceed $1.0M for 3 years period of performance\n	 \n	FY22 Ex
 ploration-Hypothesis Development Award - Anticipated total costs will not 
 exceed $250\,000 for 2 years period of performance\n	 \n	FY22 Clinical Tr
 ial Award – Two funding levels depending on the scope of the proposed re
 search:\n	 \n	\n		Funding level 1: $1.6M for 3 years\n		Funding level 2: 
 $4.5M for 4 years\n	\n	\n\n\nELIGIBILITY: EPFL researchers are eligible to
  participate even though criteria related to the experience of the PIs sho
 uld be checked. All investigators at or above the level of postdoctoral fe
 llow (or equivalent) are eligible for the Early Investigator Research Awar
 d.\n\nHOW TO APPLY: Pre-applications are submitted through the eBRAP platf
 orm. Full applications will be made via a Grants.gov workspace. Full appli
 cation packages can be downloaded from Grants.gov at any time.\n\nFOR FURT
 HER INFORMATION: Please refer to the FOAs below and feel free to contact t
 he Research Office for any question or any help.\n\n\n	FY22 Early Investig
 ator Research Award - W81XWH-22-MSRP-EIRA\n	 \n	FY22 Investigator-Initiat
 ed Research Award - W81XWH-22-MSRP-IIRA\n	 \n	FY22 Exploration-Hypothesis
  Development Award - W81XWH-22-MSRP-EHDA\n	 \n	FY22 Clinical Trial Award 
 - W81XWH-22-MSRP-CTA\n\n\n\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR